)
)
SensoDetect Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from SensoDetect
Access all reports
SensoDetect is a medical technology company specializing in the development of diagnostic tools for neuropsychiatric conditions. The company’s flagship product leverages auditory brainstem response (ABR) technology to support the assessment and identification of conditions such as ADHD, schizophrenia, and autism. SensoDetect’s solutions aim to complement traditional diagnostic methods by providing objective and efficient measurements, enabling improved decision-making in clinical settings. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
SDET
Country
🇸🇪 Sweden